Staph Wound Infections and Methicillin Resistant Staphylococcus aureus

Print this article
Share this page:


Prevention of infection is the most important target for the UK healthcare system. National efforts are underway to raise awareness of MRSA and to encourage the adoption and maintenance of preventative measures, particularly adequate hand hygiene. For more on the proper way to wash your hands, visit the Health Protection (Scotland) and Public Health England (PHE) websites.

Many institutions have put procedures in place to more rapidly recognise and address MRSA infections. Health care providers are being urged to request cultures and susceptibility testing with outpatient skin and wound infections, to monitor them carefully for effectiveness of treatment, and to be alert for the possibility of CA-MRSA. Outbreaks of CA-MRSA are being investigated and traced back to their source in order to identify the cause, to determine whether other patients may have unrecognised MRSA infections or colonisation, and to reduce the potential for additional cases.

There are multiple treatment options for patients with MRSA infections. Some antibiotics may be given orally, whilst others must be administered intravenously (IV), often for several weeks’ duration. Treatment options for significant MRSA infections include, but are not limited to, vancomycin, teicoplanin, linezolid, daptomycin, ceftaroline, ceftobiprole and chloramphenicol. .

« Prev | Next »